603229.SH
奥翔药业
SSE · Healthcare · Biotechnology · CN
CNY 7.94
−1.98%Leverage
- Debt / equity
- 0.20x
- Net debt / equity
- -0.28x
- Debt / assets
- 0.15x
- Debt / EBITDA
- 2.26x
- Net debt / EBITDA
- -3.10x
Liquidity & coverage
- Current ratio
- 2.64x
- Quick ratio
- 2.12x
- Cash ratio
- —
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- CNY 1.2B
Cash & dividend
- FCF / debt
- 0.05x
- Cash flow / debt
- 0.25x
- Dividend per share
- CNY 0.06
- Dividend yield
- 0.8%
- Dividend growth 1y
- -36.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026